We were limited to using genetic instruments for whole-blood levels of IL-6 traits, given the current lack of large-scale GWASs, and, hence, genetic instruments for IL-6 traits in tissues that are possibly more relevant to COVID-19 (e.g., lung tissue). This evidence concerns the gene IL6 and COVID-19.